A randomized, double-blind study in Brazil has found that individuals who suffer from public speaking anxiety can be helped by consuming cannabidiol (CBD). The findings of this study were released in the Brazilian Journal of Psychiatry.
Some 57 participants were recruited to take part in this study. These participants were divided into four groups with each group being given a placebo, 150mg, 300mg or 600mg of cannabidiol (CBD).
The researchers asked the participants to watch a short video and then prepare a four-minute speech based on the material in that video.
Those participants were then asked to self-assess on the anxiety levels before, during and after making that speech. The known bio-markers that are affected by public speaking anxiety, such as blood pressure, heart rate and sweating were monitored during those different stages of the presentation.
Previous studies on this same issue had suggested that CBD can mitigate public speaking anxiety depending on the dose given to the individual. The Brazilian research had similar findings.
The results revealed an inverted U when the impact of CBD on anxiety was assessed. The inverted U means that little effect was registered at lower CBD doses and the impact kept increasing until a certain point when higher doses of CBD showed a reducing effect on the “stage fright” experienced by the participants before, during and after the speech.
Specifically speaking, the group which received 150mg of CBD didn’t have any different anxiety markers from the placebo group. Similarly, those who got the higher dose of 600mg of CBD also barely differed from the placebo group.
These results show that additional studies need to be carried out to ascertain the specific “sweet spot” that provides the best effects to those who find it hard to stand before a group and express themselves coherently.
These research findings provide additional avenues through which marijuana can be harnessed to address the different challenges that people face in their day to day lives. Such research also calls for an urgent review of the scheduling of marijuana in many jurisdictions, including at the federal level in the U.S. where the plant is considered as something which doesn’t have any medical value. This categorization makes it hard for researchers to access funding to study this plant, and humanity has lost out on endless benefits during this prohibitionist period.
All isn’t lost, however, as the public is taking matters into its own hands and compelling different states to legalize marijuana through ballot measures. Cannabis companies like Green Hygienics Holdings Inc. (OTC: GRYN) and GreenBox POS, LLC (OTC: GRBX) can only wait for that time when prohibition will be ended once and for all at the federal level.
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000
For more information please visit https://www.CannabisNewsWire.com